Top Markets
Coin of the day
Zhejiang Hisun Pharmaceutical Co., Ltd. Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

600267
Rank in Stocks #6297
Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the... Zhejiang Hisun Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products. Its portfolio includes both active pharmaceutical ingredients (APIs) and finished drug formulations. The company's extensive therapeutic focus spans oncology, cardiovascular health, infectious diseases, liver support, orthopedics, parasitic infections, and immunosuppression. Additionally, Hisun Pharmaceutical addresses conditions such as weight management, viral infections, tuberculosis, and offers veterinary pharmaceuticals, among other specialized medical applications. Beyond its product lines, the firm provides product consultation and contract manufacturing/research (CMO/CRO) services. Established in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is headquartered in Taizhou, China.
Share Price
$1.79
Market Cap
$2.12B
Change (1 day)
0.65%
Change (1 year)
15.95%
Country
CN
Trade Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)

Category

P/S ratio for Zhejiang Hisun Pharmaceutical Co., Ltd. (600267)
P/S ratio as of 2026 TTM: 0
According to Zhejiang Hisun Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Zhejiang Hisun Pharmaceutical Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors